Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag
Emily Bart‐Smith, Shahram Kordasti, Austin Kulasekararaj, Daniel Richardson, Ghulam J. Mufti, Judith Marsh
Abstract
Emily Bart‐Smith, Shahram Kordasti, Austin Kulasekararaj, Daniel Richardson, Ghulam J. Mufti, Judith Marsh
Abstract
We report the first successful treatment with the thrombopoietin receptor mimetic eltrombopag in a patient with severe aplastic anaemia (SAA) associated with HIV infection, thereby avoiding the use of standard immunosuppressive agents for treatment of SAA. Eltrombopag induced a trilineage haematological response. We also show that eltrombopag had an immunomodulatory role with a decrease in proinflammatory T helpers (Th1 and Th17 cells) with increased T-regulatory cell/T-helper ratio, thus contributing to recovery of haemopoiesis.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We report the first successful treatment with the thrombopoietin receptor mimetic eltrombopag in a patient with severe aplastic anaemia (SAA) associated with HIV infection, thereby avoiding the use of standard immunosuppressive agents for treatment of SAA. Eltrombopag induced a trilineage haematological response. We also show that eltrombopag had an immunomodulatory role with a decrease in proinflammatory T helpers (Th1 and Th17 cells) with increased T-regulatory cell/T-helper ratio, thus contributing to recovery of haemopoiesis.
Key concepts: Eltrombopag, Immunology, Haematopoiesis, Medicine, Human immunodeficiency virus (HIV), Aplastic anemia, Thrombopoietin, Thrombopoietin receptor